by Tom Salemi
Numbers don't lie. By all accounts, venture capital commitments to all industries--including medical device companies--over the first quarter of this...
The financial world may be in crisis, but top-tier medical device companies can still raise capital. But at what price? Four medical device execs answer those questions and many more.
by Tom Salemi
Numbers don't lie. By all accounts, venture capital commitments to all industries--including medical device companies--over the first quarter of this...
Against a backdrop of shifting trade policies, the end of multilateral market approaches and renewed focus on supply chain resilience, medtechs are doubling down on innovation in products and processes – using AI – and keeping unmet needs and outcomes in the center of the target.
While biopharma companies experiment with genAI, agentic AI is rapidly shifting the work paradigm towards one of autonomous digital workers that can handle entire process flows.
UK biotech targets the root cause of metabolic disease while preserving muscle mass in a crowded obesity market.